Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
By Sarah J. Tabrizi, Rachael I. Scahill, G. Owen, A. Durr, B. Leavitt, Raymund A. C. Roos, B. Borowsky, B. Landwehrmeyer, C. Frost, Hans J. Johnson and 4 more. Lancet Neurology, 2013
820 citations recorded by the source corpus.
Subfields: Cellular and Molecular Neuroscience, Neurology, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/8381488a9495c253e9458b46c49497ce3ccbf8e9
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cellular and Molecular Neuroscience
In Neurology
In Psychiatry and Mental health
Citations in the corpus
- Huntington disease: natural history, biomarkers and prospects for therapeutics (2014, background): “Unbiased omics discovery approaches in CSF have not yet identified good candidate biomarkers in HD.135 Hypothesis-driven studies will focus on functional correlates and neurobiological underpinnings of detectable changes already reported, such as immune activation,40–42 transcriptional dysregulation”